Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
University College London · The George Institute for Global Health · +14 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
526
total citations
- FWCI
- 41.42
- Percentile
- 100%
- References
- 26
Citations per year
Authors
13Topics & keywords
Topics
Keywords
- Medicine
- Dapagliflozin
- Kidney disease
- Diabetes mellitus
- Adverse effect
- Disease
- Internal medicine
- Benzhydryl compounds
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.